Cancer Diagnostic Navigation and Consulting Services
Cancer Diagnostic Navigation Services
Navexio helps cancer patients get the best diagnostic tests to understand their specific type of cancer that may not be offered or available during their normal course of care.
Leaving no stone unturned and using an evidence-based approach, Navexio finds and fixes any gaps in testing, making sure patients receive the right cancer treatment planning based on their cancer’s biomarker profile. Navexio also interprets complex medical information for patients and families, helping them make informed decisions.
Comprehensive diagnostic testing is essential early in your diagnosis
Gaps in our healthcare systems can lead to insufficient diagnostic testing resulting in sub-optimal cancer treatment planning.
One of the most important steps in the early stages of a cancer diagnosis is to ensure that the cancer has been tested with the most current and comprehensive technologies to determine its molecular signature.
Many patients do not receive the most current diagnostic testing available, putting them at a disadvantage to the effective management of their cancers.
A patient’s diagnostic work-up of their cancer is dependent on the testing infrastructure available at their hospital, the patient’s type and stage of cancer, their geographic location, and/or reimbursement pathways
Why Navexio is Important for Every Cancer Patient
Leave No Stone Unturned!
At Navexio, we believe that every patient should have access to the most effective and cutting-edge diagnostic technologies available.
This ensures that the patient’s cancer genomic and biomarker information is available for their medical team to allow for the preparation and management of the most appropriate cancer treatment plan.
Comprehensive Diagnostic Navigation Support for Cancer Patients
The field of oncology and diagnostics is rapidly evolving. Navexio offers navigation consulting and cancer treatment planning services for patients and their families/ caregivers to:
ASSESS
Conduct an initial assessment of whether the best possible diagnostic tests for your cancer have been performed.
RECOMMEND
Using evidence-based medicine, provide recommendations and guidance to address the identified gap(s) by seeking additional oncogenomic testing.
INTERPRET
Interpret the molecular information from the additional diagnostic testing and work with the patient and/ or their caregiver/ medical team to determine next steps and options for cancer treatment planning.
Who are Navexio’s Diagnostic Navigators and Expert Consultants?
Navexio's diagnostic cancer navigators are accomplished and highly-experienced biomedical scientists with:
Intimate understanding of the healthcare and cancer systems in which we operate, along with the hospitals, physicians, and pathologists in its network.
Broad experience as care navigators working with patients and their families for a spectrum of solid tumor and hematologic neoplasms.
Deep knowledge of oncogenomic sequencing technologies, vendors, laboratories, and testing panels and assays.
Extensive training in oncology, molecular biology, genomics, diagnostics, and drug development.
Experience working in the pharmaceutical and biotechnology industries that provide Navexio consultants with first-hand knowledge of available therapies by jurisdiction, clinical trials, and compassion use and special access drug programs.
PhD and Post-Doctoral training.